NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024-Reference-Cited by-同舟云学术

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

Published:2023-10 Issue:10 Volume:21 Page:1000-1010
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Daly Mary B.¹,Pal Tuya²,Maxwell Kara N.³,Churpek Jane⁴,Kohlmann Wendy⁵,AlHilli Zahraa⁶,Arun Banu⁷,Buys Saundra S.⁵,Cheng Heather⁸,Domchek Susan M.³,Friedman Susan⁹,Giri Veda¹⁰,Goggins Michael¹¹,Hagemann Andrea¹²,Hendrix Ashley¹³,Hutton Mollie L.¹⁴,Karlan Beth Y.¹⁵,Kassem Nawal¹⁶,Khan Seema¹⁷,Khoury Katia¹⁸,Kurian Allison W.¹⁹,Laronga Christine²⁰,Mak Julie S.²¹,Mansour John²²,McDonnell Kevin²³,Menendez Carolyn S.²⁴,Merajver Sofia D.²⁵,Norquist Barbara S.⁸,Offit Kenneth²⁶,Rash Dominique²⁷,Reiser Gwen²⁸,Senter-Jamieson Leigha²⁹,Shannon Kristen Mahoney³⁰,Visvanathan Kala¹¹,Welborn Jeanna³¹,Wick Myra J.³²,Wood Marie³³,Yurgelun Matthew B.³⁴,Dwyer Mary A.³⁵,Darlow Susan D.³⁵

Affiliation:

1. Fox Chase Cancer Center

2. Vanderbilt-Ingram Cancer Center

3. Abramson Cancer Center at the University of Pennsylvania

4. University of Wisconsin Carbone Cancer Center

5. Huntsman Cancer Institute at the University of Utah

6. Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

7. The University of Texas MD Anderson Cancer Center

8. Fred Hutchinson Cancer Center

9. FORCE: Facing Our Risk of Cancer Empowered

10. Yale Cancer Center/Smilow Cancer Hospital

11. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

12. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

13. St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center

14. Roswell Park Comprehensive Cancer Center

15. UCLA Jonsson Comprehensive Cancer Center

16. Indiana University Melvin and Bren Simon Comprehensive Cancer Center

17. Robert H. Lurie Comprehensive Cancer Center of Northwestern University

18. O’Neal Comprehensive Cancer Center at UAB

19. Stanford Cancer Institute

20. Moffitt Cancer Center

21. UCSF Helen Diller Family Comprehensive Cancer Center

22. UT Southwestern Simmons Comprehensive Cancer Center

23. City of Hope National Medical Center

24. Duke Cancer Institute

25. University of Michigan Rogel Cancer Center

26. Memorial Sloan Kettering Cancer Center

27. UC San Diego Moores Cancer Center

28. Fred & Pamela Buffett Cancer Center

29. The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

30. Mass General Cancer Center

31. UC Davis Comprehensive Cancer Center

32. Mayo Clinic Comprehensive Cancer Center

33. University of Colorado Cancer Center

34. Dana-Farber/Brigham and Women’s Cancer Center

35. National Comprehensive Cancer Network

Abstract

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic/likely pathogenic (P/LP) variants associated with increased risk of breast, ovarian, pancreatic, and prostate cancer, including BRCA1, BRCA2, CDH1, PALB2, PTEN, and TP53, and recommended approaches to genetic counseling/testing and care strategies in individuals with these P/LP variants. These NCCN Guidelines Insights summarize important updates regarding: (1) a new section for transgender, nonbinary and gender diverse people who have a hereditary predisposition to cancer focused on risk reduction strategies for ovarian cancer, uterine cancer, prostate cancer, and breast cancer; and (2) testing criteria and management associated with TP53 P/LP variants and Li-Fraumeni syndrome.

Publisher

Harborside Press, LLC

Subject

Oncology

Link

https://jnccn.org/downloadpdf/journals/jnccn/21/10/article-p1000.xml

Reference67 articles.

1. LGBT identification in U.S. ticks up to 7.1%;Jones JM

2. About 5% of young adults in the U.S. say their gender is different from their sex assigned at birth;Brown A

3. Unanswered questions: hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults;Sutherland N,2020

4. Cancer in transgender and gender-diverse persons: a review;Leone AG,2023

5. Cohort study of cancer risk among insured transgender people;Silverberg MJ,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing;Pathology - Research and Practice;2024-02

2. Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond;Cancers;2024-01-30

3. Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A;JCO Oncology Practice;2024-01-22

4. Les actualités en génétique oncologique mammaire pour la population féminine et masculine;Gynécologie Obstétrique Fertilité & Sénologie ;2024-01

5. Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with BRCA1/2 Pathogenic Variants: A Population-Based Retrospective Cohort Study;Current Oncology;2023-10-22